North America Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Country and Growth Forecast, 2022

List of Tables

The North America Cell Viability Assays Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).

It is recommended to understand the quantity of the remaining viable cells after the experiment, regardless of the type of cell-based assay employed. Various assay methods can determine the number of viable eukaryotic cells. Some of them are resazurin reduction, protease markers, ATP detection, and tetrazolium reduction.

The tetrazolium reduction, protease activity assays, and resazurin reduction assays measure some aspect of the enzymatic activity or general metabolism as a viable cells' marker. To transform a substrate into a fluorescent or colored product that is detectable with the help of a plate reader, all of these assays require incubating a reagent with the viable cell population. A signal in proportion to the quantity of the present viable cells will be created when the substrates are set with the viable cells under most standard cultural conditions.

Most of the medical decisions rely on laboratory test results, which showcase the crucial role of clinical laboratories in the present healthcare system. According to Center of Centers for Disease Control and Preventions, annually, approximately 14 billion laboratory tests are ordered, and for an effective diagnosis and treatment of disease, quality, cost-effectiveness, and safe laboratory testing are required.

The US market dominated the North America Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $634.6 million by 2028. The Canada market is poised to grow at a CAGR of 10.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.9% during (2022 - 2028).

Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Scope of the Study

Market Segments covered in the Report:

By Product

Consumables
- Reagents & Assay Kits
Luminometric Assays
Dye Exclusion Assays
Colorimetric Assays
Fluorometric Assays
- Microplates
Instruments
- Spectrophotometer
- Microscopy
- Cell Imaging & Analysis System
- Flow Cytometry
- Others

By End User

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes
Diagnostic Labs

By Application

Stem Cell Research
Drug Discovery & Development
Diagnostics

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories Inc.
Merck KGaA
Becton, Dickinson and Company
PerkinElmer Inc.
Promega Corporation
Biotium
Creative Bioarray
Abcam Plc

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Cell Viability Assays Market, by Product
- 1.4.2 North America Cell Viability Assays Market, by End User
- 1.4.3 North America Cell Viability Assays Market, by Application
- 1.4.4 North America Cell Viability Assays Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. North America Cell Viability Assays Market by Product

4.1 North America Consumables Market by Country
4.2 North America Cell Viability Assays Market by Consumables Type
- 4.2.1 North America Reagents & Assay Kits Market by Country
- 4.2.2 North America Cell Viability Assays Market by Reagents & Assay Kits Type
  - 4.2.2.1 North America Luminometric Assays Market by Country
  - 4.2.2.2 North America Dye Exclusion Assays Market by Country
  - 4.2.2.3 North America Colorimetric Assays Market by Country
  - 4.2.2.4 North America Fluorometric Assays Market by Country
- 4.2.3 North America Microplates Market by Country
4.3 North America Instruments Market by Country
4.4 North America Cell Viability Assays Market by Instruments Type
- 4.4.1 North America Spectrophotometer Market by Country
- 4.4.2 North America Microscopy Market by Country
- 4.4.3 North America Cell Imaging & Analysis System Market by Country
- 4.4.4 North America Flow Cytometry Market by Country
- 4.4.5 North America Others Market by Country

Chapter 5. North America Cell Viability Assays Market by End-user

5.1 North America Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 North America CROs & CMOs Market by Country
5.3 North America Academic & Research Institutes Market by Country
5.4 North America Diagnostic Labs Market by Country

Chapter 6. North America Cell Viability Assays Market by Application

6.1 North America Stem Cell Research Market by Country
6.2 North America Drug Discovery & Development Market by Country
6.3 North America Diagnostics Market by Country

Chapter 7. North America Cell Viability Assays Market by Country

7.1 US Cell Viability Assays Market
- 7.1.1 US Cell Viability Assays Market by Product
  - 7.1.1.1 US Cell Viability Assays Market by Consumables Type
    - 7.1.1.1.1 US Cell Viability Assays Market by Reagents & Assay Kits Type
  - 7.1.1.2 US Cell Viability Assays Market by Instruments Type
- 7.1.2 US Cell Viability Assays Market by End-user
- 7.1.3 US Cell Viability Assays Market by Application
7.2 Canada Cell Viability Assays Market
- 7.2.1 Canada Cell Viability Assays Market by Product
  - 7.2.1.1 Canada Cell Viability Assays Market by Consumables Type
    - 7.2.1.1.1 Canada Cell Viability Assays Market by Reagents & Assay Kits Type
  - 7.2.1.2 Canada Cell Viability Assays Market by Instruments Type
- 7.2.2 Canada Cell Viability Assays Market by End-user
- 7.2.3 Canada Cell Viability Assays Market by Application
7.3 Mexico Cell Viability Assays Market
- 7.3.1 Mexico Cell Viability Assays Market by Product
  - 7.3.1.1 Mexico Cell Viability Assays Market by Consumables Type
    - 7.3.1.1.1 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type
  - 7.3.1.2 Mexico Cell Viability Assays Market by Instruments Type
- 7.3.2 Mexico Cell Viability Assays Market by End-user
- 7.3.3 Mexico Cell Viability Assays Market by Application
7.4 Rest of North America Cell Viability Assays Market
- 7.4.1 Rest of North America Cell Viability Assays Market by Product
  - 7.4.1.1 Rest of North America Cell Viability Assays Market by Consumables Type
    - 7.4.1.1.1 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type
  - 7.4.1.2 Rest of North America Cell Viability Assays Market by Instruments Type
- 7.4.2 Rest of North America Cell Viability Assays Market by End-user
- 7.4.3 Rest of North America Cell Viability Assays Market by Application

Chapter 8. Company Profiles

8.1 Thermo Fisher Scientific, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Partnerships, Collaborations, and Agreements:
  - 8.1.5.2 Product Launches and Product Expansions:
  - 8.1.5.3 Acquisition and Mergers:
  - 8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
  - 8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Product Launches and Product Expansions:
  - 8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Product Launches and Product Expansions:
  - 8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
8.7 Abcam plc
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
8.8 Promega Corporation
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
  - 8.8.2.1 Partnerships, Collaborations, and Agreements:
  - 8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
- 8.9.1 Company Overview
8.10. Biotium, Inc.
- 8.10.1 Company Overview

LIST OF TABLES

TABLE 1 North America Cell Viability Assays Market, 2018 - 2021, USD Million
TABLE 2 North America Cell Viability Assays Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Cell Viability Assays Market
TABLE 4 Product Launches And Product Expansions- Cell Viability Assays Market
TABLE 5 Acquisition and Mergers- Cell Viability Assays Market
TABLE 6 North America Cell Viability Assays Market by Product, 2018 - 2021, USD Million
TABLE 7 North America Cell Viability Assays Market by Product, 2022 - 2028, USD Million
TABLE 8 North America Consumables Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Consumables Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
TABLE 11 North America Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
TABLE 12 North America Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
TABLE 15 North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
TABLE 16 North America Luminometric Assays Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Luminometric Assays Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Colorimetric Assays Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Colorimetric Assays Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Fluorometric Assays Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Fluorometric Assays Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Microplates Market by Country, 2018 - 2021, USD Million
TABLE 25 North America Microplates Market by Country, 2022 - 2028, USD Million
TABLE 26 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 27 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
TABLE 29 North America Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
TABLE 30 North America Spectrophotometer Market by Country, 2018 - 2021, USD Million
TABLE 31 North America Spectrophotometer Market by Country, 2022 - 2028, USD Million
TABLE 32 North America Microscopy Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Microscopy Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
TABLE 35 North America Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
TABLE 36 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 39 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 40 North America Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
TABLE 41 North America Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
TABLE 42 North America Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 43 North America Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 44 North America CROs & CMOs Market by Country, 2018 - 2021, USD Million
TABLE 45 North America CROs & CMOs Market by Country, 2022 - 2028, USD Million
TABLE 46 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 47 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 48 North America Diagnostic Labs Market by Country, 2018 - 2021, USD Million
TABLE 49 North America Diagnostic Labs Market by Country, 2022 - 2028, USD Million
TABLE 50 North America Cell Viability Assays Market by Application, 2018 - 2021, USD Million
TABLE 51 North America Cell Viability Assays Market by Application, 2022 - 2028, USD Million
TABLE 52 North America Stem Cell Research Market by Country, 2018 - 2021, USD Million
TABLE 53 North America Stem Cell Research Market by Country, 2022 - 2028, USD Million
TABLE 54 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 56 North America Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Cell Viability Assays Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Cell Viability Assays Market by Country, 2022 - 2028, USD Million
TABLE 60 US Cell Viability Assays Market, 2018 - 2021, USD Million
TABLE 61 US Cell Viability Assays Market, 2022 - 2028, USD Million
TABLE 62 US Cell Viability Assays Market by Product, 2018 - 2021, USD Million
TABLE 63 US Cell Viability Assays Market by Product, 2022 - 2028, USD Million
TABLE 64 US Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
TABLE 65 US Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
TABLE 66 US Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
TABLE 67 US Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
TABLE 68 US Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
TABLE 69 US Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
TABLE 70 US Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
TABLE 71 US Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
TABLE 72 US Cell Viability Assays Market by Application, 2018 - 2021, USD Million
TABLE 73 US Cell Viability Assays Market by Application, 2022 - 2028, USD Million
TABLE 74 Canada Cell Viability Assays Market, 2018 - 2021, USD Million
TABLE 75 Canada Cell Viability Assays Market, 2022 - 2028, USD Million
TABLE 76 Canada Cell Viability Assays Market by Product, 2018 - 2021, USD Million
TABLE 77 Canada Cell Viability Assays Market by Product, 2022 - 2028, USD Million
TABLE 78 Canada Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
TABLE 79 Canada Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
TABLE 80 Canada Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
TABLE 81 Canada Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
TABLE 82 Canada Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
TABLE 83 Canada Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
TABLE 84 Canada Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
TABLE 85 Canada Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
TABLE 86 Canada Cell Viability Assays Market by Application, 2018 - 2021, USD Million
TABLE 87 Canada Cell Viability Assays Market by Application, 2022 - 2028, USD Million
TABLE 88 Mexico Cell Viability Assays Market, 2018 - 2021, USD Million
TABLE 89 Mexico Cell Viability Assays Market, 2022 - 2028, USD Million
TABLE 90 Mexico Cell Viability Assays Market by Product, 2018 - 2021, USD Million
TABLE 91 Mexico Cell Viability Assays Market by Product, 2022 - 2028, USD Million
TABLE 92 Mexico Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
TABLE 93 Mexico Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
TABLE 94 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
TABLE 95 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
TABLE 96 Mexico Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
TABLE 97 Mexico Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
TABLE 98 Mexico Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
TABLE 99 Mexico Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
TABLE 100 Mexico Cell Viability Assays Market by Application, 2018 - 2021, USD Million
TABLE 101 Mexico Cell Viability Assays Market by Application, 2022 - 2028, USD Million
TABLE 102 Rest of North America Cell Viability Assays Market, 2018 - 2021, USD Million
TABLE 103 Rest of North America Cell Viability Assays Market, 2022 - 2028, USD Million
TABLE 104 Rest of North America Cell Viability Assays Market by Product, 2018 - 2021, USD Million
TABLE 105 Rest of North America Cell Viability Assays Market by Product, 2022 - 2028, USD Million
TABLE 106 Rest of North America Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
TABLE 107 Rest of North America Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
TABLE 108 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
TABLE 109 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
TABLE 110 Rest of North America Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
TABLE 111 Rest of North America Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
TABLE 112 Rest of North America Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
TABLE 113 Rest of North America Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
TABLE 114 Rest of North America Cell Viability Assays Market by Application, 2018 - 2021, USD Million
TABLE 115 Rest of North America Cell Viability Assays Market by Application, 2022 - 2028, USD Million
TABLE 116 Key Information - Thermo Fisher Scientific, Inc.
TABLE 117 key Information - Agilent Technologies, Inc.
TABLE 118 Key Information - Bio-Rad Laboratories, Inc.
TABLE 119 Key information - Becton, Dickinson and Company
TABLE 120 key Information - PerkinElmer, Inc.
TABLE 121 key Information - Merck KGaA
TABLE 122 key information - Abcam plc
TABLE 123 key Information - Promega Corporation
TABLE 124 Key Information - Creative Bioarray
TABLE 125 Key Information - Biotium, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Thermo Fisher Scientific Inc.
FIG 5 Recent strategies and developments: Becton, Dickinson and Company

North America Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents